Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109734662A reveals metal-free trifluoromethylation. Offers cost reduction and scalable supply for high-purity pharmaceutical intermediates globally.
Patent CN108610304B details a novel Pd-catalyzed C-H activation route for diaryl sultams, offering superior atom economy and simplified supply chains for pharmaceutical intermediates.
New one-step synthesis route for indole carbazoles reduces costs and improves scalability for pharmaceutical intermediate manufacturing supply chains.
Patent CN118619879A reveals a Rh-catalyzed route for trifluoromethyl enaminones, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation patent CN114751883B offers efficient synthesis. Reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates.
Novel elemental sulfur-promoted method for high-purity triazole intermediates. Reduces cost and improves supply chain reliability for pharma manufacturing.
Patent CN115286578B reveals a metal-free route for trifluoromethyl pyrazole compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel visible-light driven Ru-catalyst enables room-temp alkyne-aldehyde addition. Reduces energy costs and simplifies supply chain for API synthesis.
Novel iridium catalyzed asymmetric synthesis offers high enantioselectivity. Reduces costs and improves supply chain reliability for pharmaceutical intermediates globally.
This report analyzes patent CN103804187B for Jacaronic Acid A synthesis offering scalable production and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel one-pot synthesis of quinone thiazole compounds. Reduces steps, eliminates toxic oxidants. Reliable pharmaceutical intermediate supplier for scale-up.
Novel 4-step enzymatic route for Ritlecitinib Tosylate. Eliminates metal catalysts and chiral columns. High purity, scalable supply for global pharma partners.
Patent CN108610304A reveals a novel Pd-catalyzed route for diarylsultams, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed carbonylation route offers high yields and broad substrate scope for drug molecule synthesis, ensuring reliable supply chain solutions.
Novel biaryl ligand synthesis via Catellani reaction offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Novel heating-promoted synthesis of 2-trifluoromethyl quinoline. Metal-free, green chemistry, cost-effective for pharma intermediates. Reliable supply chain partner.
Patent CN115353482B reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN115925527B details a Ru-catalyzed method for high-purity API intermediate synthesis, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN113307778A details a novel Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate suppliers.
Patent CN113121462A reveals a metal-free route for 5-trifluoromethyl-1,2,3-triazoles. This method offers cost reduction in pharmaceutical intermediate manufacturing via mild conditions.